Skip to content
StockMarketAgent
Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

HQY stock hub

HealthEquity, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HQYis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
7.2B
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
HQY
In the news

Latest news · HQY

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.3
P25 12.6P50 18.3P75 33.7
Trailing P/E34.5
P25 15P50 23.3P75 38.5
ROE10.2
P25 -106.6P50 -46.9P75 -3.1
ROIC9
P25 -63.1P50 -27.5P75 -0
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HQY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
255
Groups with data
11
Currency
USD
Showing 255 of 255 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001428336
Company name
HealthEquity, Inc.
Country
United States
Country code
US
Cusip
42226A107
Employees
2,814
Employees Change
-306%
Employees Change Percent
-9.81
Enterprise value
$7.8B
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Health Information Services
IPO Date
2014-07-31
Isin
US42226A1079
Last refreshed
2026-05-10
Market cap
$7.2B
Market cap category
Mid-Cap
Price
$84.84
Price currency
USD
Rev Per Employee
466,748.05x
Sector
Healthcare
Sic
7389
Symbol
HQY
Website
https://www.healthequity.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

17
MetricValue
Earnings Yield
3%
EV Earnings
36.48x
EV Sales Forward
5.51x
EV/EBIT
23.97x
EV/EBITDA
16.28x
EV/FCF
17.25x
EV/Sales
5.98x
FCF yield
6.35%
Forward P/E
18.34x
P/B ratio
3.42x
P/E ratio
34.49x
P/S ratio
5.46x
PE Ratio10 Y
464.65x
PE Ratio3 Y
118.16x
PE Ratio5 Y
866.78x
PEG ratio
1.34x
PS Forward
5.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
24.93%
EBITDA Margin
36.71%
FCF margin
34.65%
Gross margin
69.52%
Gross Profit
$913.1M
Gross Profit Growth
17.48%
Gross Profit Growth Q
20.69%
Gross Profit Growth3 Y
22.9%
Gross Profit Growth5 Y
17.06%
Net Income
$215.2M
Net Income Growth
122.54%
Net Income Growth Q
88.66%
Net Income Growth Quarters
5%
Net Income Growth Years
4%
Net Income Growth5 Y
89.38%
Pretax Margin
21.12%
Profit Margin
16.38%
Profit Per Employee
$76,475
Profitable Years
3
ROA
5.99
Roa5y
2.8
ROCE
10.16
ROE
10.19
Roe5y
2.71
ROIC
9
Roic5y
4.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

24
MetricValue
Cagr10y
12.85%
Cagr1y
-7.51%
Cagr3y
15.72%
Cagr5y
2.63%
EPS Growth
125.7
EPS Growth Q
92.41
EPS Growth Quarters
4
EPS Growth Years
4
EPS Growth5 Y
83.26
FCF Growth
34.74%
FCF Growth Q
55.91%
FCF Growth3 Y
45.66%
FCF Growth5 Y
21.98%
OCF Growth
34.5%
OCF Growth Q
55.67%
OCF Growth10 Y
32.93%
OCF Growth3 Y
44.77%
OCF Growth5 Y
20.27%
Revenue Growth
9.47x
Revenue Growth Q
7.3x
Revenue Growth Quarters
19x
Revenue Growth Years
13x
Revenue Growth3 Y
15.08x
Revenue Growth5 Y
12.36x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
$0.38
Assets
$3.4B
Cash
$318.9M
Current Assets
$512.3M
Current Liabilities
$156.9M
Debt
$1B
Debt EBITDA
$2.06
Debt Equity
$0.48
Debt FCF
$2.2
Equity
$2.1B
Interest Coverage
5.73
Liabilities
$1.3B
Long Term Assets
$2.9B
Long Term Liabilities
$1.1B
Net Cash
$-682.6M
Net Cash By Market Cap
$-9.52
Net Debt EBITDA
$1.42
Net Debt Equity
$0.32
Net Debt FCF
$1.5
Tangible Book Value
$-638.1M
Tangible Book Value Per Share
$-7.51
WACC
5.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
3.27
Net Working Capital
$46.4M
Quick ratio
2.82
Working Capital
$355.4M
Working Capital Turnover
$3.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
1.53%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
234.81%
1Y total return
-7.5%
200-day SMA
89.02
3Y total return
54.96%
50-day SMA
81.54
50-day SMA vs 200-day SMA
50under200
5Y total return
13.83%
All Time High
116.7
All Time High Change
-27.27%
All Time High Date
2025-06-05
All Time Low
15.8
All Time Low Change
436.96%
All Time Low Date
2016-02-05
ATR
2.8
Beta
0.19
Beta1y
0.83
Beta2y
0.94
Ch YTD
-7.39
High
84.99
High52
116.7
High52 Date
2025-06-05
High52ch
-27.27%
Low
82.63
Low52
72.76
Low52 Date
2026-02-17
Low52ch
16.6%
Ma50ch
4.05%
Price vs 200-day SMA
-4.7%
RSI
56.66
RSI Monthly
48.78
RSI Weekly
49.17
Sharpe ratio
-0.15x
Sortino ratio
-0.05
Total Return
1.53%
Tr YTD
-7.39
Tr1m
4.64%
Tr1w
2.96%
Tr3m
6.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

18
MetricValue
Analyst Count
14
Analyst Count Top
2
Analyst Price Target Top
$115
Analyst Ratings
Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$1.08
Earnings EPS Estimate Growth
11.34
Earnings Revenue Estimate
352,622,792x
Earnings Revenue Estimate Growth
6.6x
Operating Income
$327.5M
Operating Income Growth
61.42
Operating Income Growth Q
63.32
Operating Income Growth3 Y
105.6
Operating Income Growth5 Y
32.56
Operating margin
24.93
Price target
$115
Price Target Change
$35.55
Price Target Change Top
$35.55

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
82,812,792%
Float Percent
98.03%
Net Borrowing
-100,000,000
Shares Insiders
1.94%
Shares Institutions
107.92%
Shares Out
84,478,406
Shares Qo Q
-0.78%
Shares Yo Y
-1.53%
Short Float
4.97%
Short Ratio
3.94
Short Shares
4.87

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

67
MetricValue
Adjusted FCF
$382.1M
Average Volume
884,704.65x
Bv Per Share
24.79
CAPEX
$-2M
Ch10y
234.8
Ch1m
4.64
Ch1w
2.96
Ch1y
-7.5
Ch3m
6.78
Ch3y
54.96
Ch5y
13.83
Ch6m
-9.47
Change
1.01%
Change From Open
1.45
Close
83.99
Days Gap
-0.43
Depreciation Amortization
154,657,000
Dollar Volume
56,936,208.8
Earnings Date
2026-05-28
Earnings Time
amc
EBIT
$327.5M
EBITDA
$482.1M
EPS
$2.46
F Score
8
FCF
$455.1M
FCF EV Yield
5.8x
FCF Per Share
$5.39
Financing CF
-386,975,000
Fiscal Year End
January
Founded
2,002
Goodwill
1,648,145,000
Graham Number
37.0411
Graham Upside
-56.34
Income Tax
$62.2M
Investing CF
-47,140,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-17
Last Report Date
2026-01-31
Last Split Type
Never
Last10k Filing Date
2026-03-17
Lynch Fair Value
$61.5
Lynch Upside
-27.51
Ma150
87.9
Ma150ch
-3.48%
Ma20
82.84
Ma20ch
2.42%
Net CF
22,979,000
Next Earnings Date
2026-05-28
Open
83.63
Optionable
Yes
P FCF Ratio
15.75
P OCF Ratio
15.68
Position In Range
93.64
Ppne
39,487,000
Price Date
2026-05-08
Price EBITDA
$14.87
Relative Volume
0.76x
Revenue
1,313,429,000x
SBC By Revenue
5.56x
Share Based Comp
73,063,000
Tax By Revenue
4.74x
Tax Rate
22.43%
Tr6m
-9.47%
Us State
Utah
Volume
671,101
Z Score
4.8
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does HQY pay a dividend?

Capital-return profile for this ticker.

Performance

HQY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-7.5%
S&P 500 1Y: n/a
3Y total return
+55.0%
S&P 500 3Y: n/a
5Y total return
+13.8%
S&P 500 5Y: n/a
10Y total return
+234.8%
S&P 500 10Y: n/a
Ownership

Who owns HQY?

Insider, institutional, and short-interest positioning.

Institutional ownership
+107.9%
Float: +98.0% of shares outstanding
Insider ownership
+1.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+5.0%
3.9 days to cover
Y/Y dilution
-1.5%
Negative means the company is buying back shares.
Technical

HQY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
56.7
Neutral momentum band
Price vs 200-day MA
-4.7%
50/200-day relationship not available
Beta (5Y)
0.19
Less volatile than the market
Sharpe ratio
-0.15
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HQY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current HQY stock rating?

HealthEquity, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full HQY analysis?

The full report lives at /stocks/HQY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for HQY?

The latest report frames HQY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the HQY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.